OPTIRAY Imaging Bulk Package - 350, 500mL, Vial, Nationwide and Mexico recall: Particulate Matter
Official notice: Liebel-Flarsheim Company, LLC Issues Recall of OPTIRAY Imaging Bulk Package - 350, 500mL, Vial, Nationwide and Mexico Due to Presence of Particulate Matter
What happened
Liebel-Flarsheim Company, LLC is recalling one lot of OPTIRAY Imaging Bulk Package 350, 500mL vial (Ioversol Injection 74% 350 mg iodine/ml), a radiographic contrast agent used for intra-arterial or intra-venous injection. The FDA published the recall notice on August 4, 2026 due to particulate matter of polyethylene and other plastics, stainless steel and glass. The company is notifying distributors and customers and arranging return and replacement of the recalled products.
Affected products
- OPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vial, cases of 6 vials
- NDC 0019-1333-65, Lot 25ZF3670, Expiration May 31, 2027
- Distributed in the United States and Mexico to distributors and end users such as hospitals, imaging centers, and clinics
The risk
The source says injecting a product containing particulate matter may cause local irritation or swelling. In compromised patients, it may cause serious life-threatening events such as blockage of blood vessels and blood clots. The company has not received any reports of adverse events related to this issue.
What to do
Healthcare providers holding the recalled product should immediately stop use and distribution, quarantine affected inventory, and return the lot to Liebel-Flarsheim as the customer recall notice instructs. Consumers with questions can contact Liebel-Flarsheim Company, LLC. Patients with problems possibly related to the drug should contact their physician or healthcare provider. Problems may be reported to the FDA MedWatch program.
Summary of the official notice, written with AI. Check the notice for full details.
This recall was published by U.S. Food & Drug Administration (FDA). View the full official notice for complete details, affected product codes, and what to do next.
View the full official notice